Endocrine Pathways of Kisspeptin and HCG: A Clinical Overview

by Dr. James Ross

Disclaimer: All articles and product details provided on this website are intended for educational and informational purposes only. The products listed here are for in-vitro research only. In-vitro studies are conducted outside of living organisms. These products are not intended as medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. The direct or indirect administration of these substances to humans or animals is unequivocally prohibited under applicable law.

Kisspeptin and Regulation of Fat Metabolism

Kisspeptin-10 has been shown to influence fat cell development and metabolism. In laboratory studies using 3T3-L1 cells, it reduced cell proliferation and adipogenesis while lowering expression of genes such as PPAR-γ and CEBPβ, both of which play central roles in fat cell differentiation. At the same time, it promoted lipolysis in both 3T3-L1 cells and rat adipocytes by increasing expression of perilipin and hormone-sensitive lipase. Kisspeptin also affected glucose uptake, lipid synthesis, and altered adipokine secretion, with findings showing elevated leptin release and reduced adiponectin levels.

Kisspeptin and Bone Formation

Kisspeptin-10 has demonstrated the ability to stimulate osteoblast activity and enhance bone formation through GPR54 signaling pathways. Research indicates that it increases expression of bone morphogenetic protein 2 (BMP2), which drives osteoblast differentiation. Activation of downstream transcription factors such as Runx2, alkaline phosphatase (ALP), and Dlx5 were observed in treated cells. The mechanism involved NFATc4-mediated regulation of BMP2. Importantly, these effects were absent in GPR54-deficient cells, confirming receptor-specific action. These findings suggest kisspeptin enhances skeletal development by turning progenitor cells into osteoblasts.

Kisspeptin and Testosterone Regulation

Kisspeptin acts at the hypothalamic level, stimulating gonadotropin-releasing hormone (GnRH) neurons. This leads to pituitary release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). LH primarily triggers testosterone release in the testes, while FSH supports spermatogenesis. This cascade represents the natural feedback loop that regulates male reproductive function. By targeting the hypothalamus, kisspeptin activates the entire hormonal axis from the top down, unlike direct stimulation at the gonadal level.

Long-Term Effects on LH and Testosterone

Concerns about receptor desensitization have been evaluated in human studies. While the kisspeptin receptor (KISS1R) can rapidly desensitize in vitro, continuous infusion of kisspeptin-10 in men for nearly 23 hours showed no reduction in LH secretion. Instead, secretion appeared to rise gradually with no evidence of tachyphylaxis at the doses tested. By contrast, in women, repeated administration of kisspeptin-54 over two weeks has been associated with diminished LH responses. This suggests sex-specific differences in desensitization patterns.

Kisspeptin, GnRH, and Neuroprotection

GnRH itself has documented benefits in the central nervous system, with evidence of neurotrophic, neuroprotective, and neuroregenerative properties in patients with brain or spinal cord injuries. GnRH and its receptors are present throughout the cerebral cortex, where they may function as neuromodulators. These findings expand the potential role of kisspeptin-induced GnRH release beyond reproductive physiology and into neurological health.

Kisspeptin and Calcium Signaling

Activation of GPR54 by kisspeptin-10 initiates intracellular calcium signaling pathways. This occurs via phospholipase C activation, leading to Ca²⁺ release and downstream activation of protein kinase C (PKC). In neuronal and reproductive cells, kisspeptin increased calcium oscillations and spiking frequency, sometimes producing plateau-like bursts. These responses have been linked to cardiac-related gene expression changes, including ITGA4 and ITGB8, which are associated with cardiomyopathies. In hippocampal neurons, kisspeptin-10 also triggered calcium transients, an effect blocked by PKC inhibitors. This indicates a potential role in modulating neuronal activity and memory functions.

See more: epithalon

REFERENCES

1. Serhatlioglu I, Yuksel H, Kacar E, Ozcan S, Canpolat S, Ozcan M, Ayar A, Kelestimur H. Kisspeptin increases intracellular calcium concentration by protein kinase C-mediated signaling in the primary cultured neurons from rat hippocampus. Cell Mol Biol (Noisy-le-grand). 2018 May 30;64(7):56-59. PMID: 29974847.
2. Zhang Y, Hou Y, Wang X, Ping J, Ma Z, Suo C, Lei Z, Li X, Zhang Z, Jia C, Su J. The effects of kisspeptin-10 on serum metabolism and myocardium in rats. PLoS One. 2017 Jul 10;12(7):e0179164. doi: 10.1371/journal.pone.0179164. PMID: 28692647; PMCID: PMC5503227.
3. Martínez-Moreno CG, Calderón-Vallejo D, Harvey S, Arámburo C, Quintanar JL. Growth Hormone (GH) and Gonadotropin-Releasing Hormone (GnRH) in the Central Nervous System: A Potential Neurological Combinatory Therapy? Int J Mol Sci. 2018 Jan 26;19(2):375. doi: 10.3390/ijms19020375. PMID: 29373545; PMCID: PMC5855597.
4. Pruszyńska-Oszmałek E, Kołodziejski PA, Sassek M, Sliwowska JH. Kisspeptin-10 inhibits proliferation and regulates lipolysis and lipogenesis processes in 3T3-L1 cells and isolated rat adipocytes. Endocrine. 2017 Apr;56(1):54-64. doi: 10.1007/s12020-017-1248-y. Epub 2017 Feb 13. PMID: 28194651.
5. Chan YM. Effects of kisspeptin on hormone secretion in humans. Adv Exp Med Biol. 2013;784:89-112. doi: 10.1007/978-1-4614-6199-9_5. PMID: 23550003.

Product available for research use only: